Clinical Trial Update: Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery [Phase 3]

View source ↗

Summary

Phase 3 trial of Recombinant Human Antithrombin (rhAT) in patients with hereditary antithrombin deficiency undergoing surgery or delivery has completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antithrombin Deficiency

Drugs mentioned

• Recombinant Human Antithrombin (rhAT) (recombinant human antithrombin)

Snippet

Sponsor: rEVO Biologics | Conditions: Antithrombin III Deficiency | Phase 3 | Status: COMPLETED | Results posted: 2012-05-11